Molecular aspects, clinical aspects and possible treatment modalities for Costello syndrome: Proceedings from the 1st International Costello Syndrome Research Symposium 2007.
Rauen
Katherine A
KA
Department of Pediatrics, Division of Medical Genetics, University of California, San Francisco, California, USA. rauen@cc.ucsf.edu
Hefner
Erin
E
Carrillo
Kristin
K
Taylor
Jill
J
Messier
Laure
L
Aoki
Yoko
Y
Gripp
Karen W
KW
Matsubara
Yoichi
Y
Proud
Virginia K
VK
Hammond
Peter
P
Allanson
Judith E
JE
Delrue
Marie-Ange
MA
Axelrad
Marni E
ME
Lin
Angela E
AE
Doyle
Daniel A
DA
Kerr
Bronwyn
B
Carey
John C
JC
McCormick
Frank
F
Silva
Alcino J
AJ
Kieran
Mark W
MW
Hinek
Aleksander
A
Nguyen
Tan T
TT
Schoyer
Lisa
L
D000015:Abnormalities, Multiple / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy*; D002809:Chondroitin Sulfates / Q000378:metabolism; D019465:Craniofacial Abnormalities / Q000235:genetics; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D051231:Farnesyltranstransferase / Q000037:antagonists & inhibitors; D011905:Genes, ras; D005838:Genotype; D018095:Germ-Line Mutation; D006330:Heart Defects, Congenital / Q000235:genetics; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000235:genetics; D010641:Phenotype; D013577:Syndrome
D004791:Enzyme Inhibitors; D019382:Human Growth Hormone; D002809:Chondroitin Sulfates; D051231:Farnesyltranstransferase